Edition:
United Kingdom

Histogenics Corp (HSGX.OQ)

HSGX.OQ on NASDAQ Stock Exchange Capital Market

2.57USD
22 Jan 2018
Change (% chg)

-- (--)
Prev Close
$2.57
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
17,614
52-wk High
$3.12
52-wk Low
$1.46

Select another date:

BRIEF-Histogenics Announces Pricing Of Underwritten Registered Direct Offering

* ANNOUNCES PRICING OF UNDERWRITTEN REGISTERED DIRECT OFFERING OF 2,340,430 SHARES OF COMMON STOCK

BRIEF-Histogenics And Medinet Enter Licensing Agreement For Commercialization Of NeoCart In Japan

* HISTOGENICS CORPORATION AND MEDINET CO., LTD ENTER INTO LICENSING AGREEMENT FOR DEVELOPMENT AND COMMERCIALIZATION OF NEOCART FOR THE JAPANESE MARKET

BRIEF-MEDINET signs license contract for NeoCart with Histogenics

* Says it entered into a license contract for development and sale of autologous cultured chondrocyte named NeoCart, with Histogenics Corp

BRIEF-Histogenics Corp announces Q3 loss per share $0.23

* Histogenics Corporation announces third quarter 2017 financial and operating results

BRIEF-Histogenics Corp promotes Stephen Kennedy to COO

* Histogenics Corporation promotes Stephen Kennedy to executive vice president & chief operating officer Source text for Eikon: Further company coverage:

BRIEF-Histogenics says Q2 loss per share $0.25

* Histogenics corporation announces second quarter 2017 financial and operating results

Select another date: